Creo Medical Group PLC (CREO) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.684x

Based on the latest financial reports, Creo Medical Group PLC (CREO) has a cash flow conversion efficiency ratio of -0.684x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-34.20 Million ≈ $-4.16K USD) by net assets (GBX50.00 Million ≈ $6.08K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Creo Medical Group PLC stock valuation for the company's overall valuation and market capitalisation.

Creo Medical Group PLC - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Creo Medical Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Creo Medical Group PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Creo Medical Group PLC ranked by their cash flow conversion efficiency. Explore cash flow quality index of Creo Medical Group PLC to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
RightBridge Ventures Group AB ST:RIGHTB	0.172x
Aesthetic Medical International Holdings Group Limited NASDAQ:PAIYY	-0.054x
Lucky Minerals Inc V:LKY	0.000x
Gemfields Plc LSE:GEM	0.044x
ARCTIC BLUE BEVERAGES AB F:U5L	0.143x
Tongyang Inc KO:001527	-0.030x
Kollect on Demand Holding Ab ST:KOLL	-0.012x
TTL Beteiligungs- und Grundbesitz-AG F:TTO	0.226x

Annual Cash Flow Conversion Efficiency for Creo Medical Group PLC (2014–2025)

The table below shows the annual cash flow conversion efficiency of Creo Medical Group PLC from 2014 to 2025. View Creo Medical Group PLC stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX50.00 Million ≈ $6.08K	GBX-18.60 Million ≈ $-2.26K	-0.372x	+28.95%
2024-12-31	GBX42.40 Million ≈ $5.16K	GBX-22.20 Million ≈ $-2.70K	-0.524x	-44.96%
2023-12-31	GBX59.80 Million ≈ $7.28K	GBX-21.60 Million ≈ $-2.63K	-0.361x	+28.59%
2022-12-31	GBX49.40 Million ≈ $6.01K	GBX-24.99 Million ≈ $-3.04K	-0.506x	-42.74%
2021-12-31	GBX73.32 Million ≈ $8.92K	GBX-25.98 Million ≈ $-3.16K	-0.354x	-38.36%
2020-12-31	GBX62.81 Million ≈ $7.64K	GBX-16.09 Million ≈ $-1.96K	-0.256x	-83.44%
2019-12-31	GBX82.66 Million ≈ $10.06K	GBX-11.54 Million ≈ $-1.40K	-0.140x	+53.07%
2018-12-31	GBX47.71 Million ≈ $5.81K	GBX-14.20 Million ≈ $-1.73K	-0.298x	+68.83%
2018-06-30	GBX7.33 Million ≈ $891.73	GBX-7.00 Million ≈ $-851.17	-0.955x	-102.27%
2017-06-30	GBX14.65 Million ≈ $1.78K	GBX-6.91 Million ≈ $-841.33	-0.472x	+53.13%
2016-06-30	GBX1.63 Million ≈ $198.22	GBX-1.64 Million ≈ $-199.58	-1.007x	-3.79%
2016-02-29	GBX3.22 Million ≈ $392.03	GBX-3.13 Million ≈ $-380.30	-0.970x	+68.09%
2015-02-28	GBX748.41K ≈ $91.06	GBX-2.27 Million ≈ $-276.80	-3.040x	-206.94%
2014-02-28	GBX1.37 Million ≈ $167.26	GBX-1.36 Million ≈ $-165.64	-0.990x	--

About Creo Medical Group PLC

LSE:CREO UK Medical Devices

Market Cap

$724.08K

GBX5.95 Billion GBX

Market Cap Rank

#30871 Global

#864 in UK

Share Price

GBX12.25

Change (1 day)

+0.00%

52-Week Range

GBX9.90 - GBX17.75

All Time High

GBX243.00